1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Oral Session

Start Session

ALL - 1317

Outcomes After TKI Discontinuation in Patients with Ph+ ALL Treated With Blinatumomab and Ponatinib

Abigail Huetteman

Poster Presenter: Abigail Huetteman

$Thumbnail for Ofirnoflast (HT-6184), a First-in-Class Allosteric NEK7 Inhibitor, Achieves Durable Transfusion Independence (TI) and Hematological Improvement-Erythroid (HI-E) in ESA-Refractory Lower-Risk Myelodysplastic Syndrome (LR-MDS): Phase 2 Final Results$

MDS - 812

Ofirnoflast (HT-6184), a First-in-Class Allosteric NEK7 Inhibitor, Achieves Durable Transfusion Independence (TI) and Hematological Improvement-Erythroid (HI-E) in ESA-Refractory Lower-Risk Myelodysplastic Syndrome (LR-MDS): Phase 2 Final Results

Amit Verma

Poster Presenter: Amit Verma

MPN - 120

RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

Naseema Gangat

Poster Presenter: Naseema Gangat

Thumbnail for Restore-PV: A Phase 2 Open-Label Study Evaluating the Safety and Efficacy of the Anti-TMPRSS6 Monoclonal Antibody DISC-3405 in Participants with Polycythemia Vera

MPN - 099

Restore-PV: A Phase 2 Open-Label Study Evaluating the Safety and Efficacy of the Anti-TMPRSS6 Monoclonal Antibody DISC-3405 in Participants with Polycythemia Vera

Naseema Gangat

Poster Presenter: Naseema Gangat

MM - 218

Phase 3 Randomized Trial of Anselamimab Demonstrates Improvement in All-Cause Mortality in ? Light-Chain Amyloidosis

Giada Bianchi

Poster Presenter: Giada Bianchi

$Thumbnail for Phase 3 Results From the EPCORE FL-1 Trial of Epcoritamab (E) With Lenalidomide and Rituximab (R2) versus R2 for Relapsed or Refractory Follicular Lymphoma (R/R FL)$